There and Back Again: The Journey of the Estrogen-Related Receptors in the Cancer Realm|
The authors discuss how the estrogen-related receptors occupy a central node at the interface of cancer and metabolism, and that modulation of their activity may represent a worthwhile strategy to induce metabolic vulnerability in tumors of various origins and thus achieve a more comprehensive response to current therapies. [J Steroid Biochem Mol Biol] Abstract
Visit our reviews page to see a complete list of reviews in the mammary cell research field.
Prima Biomed Receives Positive Scientific Advice from the European Medicines Agency for Its Lead Product, IMP321|
Prima BioMed Ltd announced that it has received positive scientific advice from the European Medicines Agency on the development path for its lead product IMP321 in metastatic breast cancer. [Prima BioMed Ltd] Press Release
Celsion Announces Continuing Positive Data from Its Phase II DIGNITY Study in Breast Cancer
Celsion Corporation announced positive interim data from its ongoing open-label Phase II DIGNITY Trial of ThermoDox® in recurrent chest wall breast cancer. [Celsion Corporation] Press Release
$1.8 Million NCI Award Helps Researcher Study Protein’s Effect on Breast Cancer
Xiaoting Zhang, PhD, associate professor in the Department of Cancer Biology at the University of Cincinnati College of Medicine, has received a $1.8 million, five-year, R01 award from the National Cancer Institute (NCI) to continue breast cancer research focusing on the function of the protein MED1 on HER2-positive breast cancer. [University of Cincinnati College of Medicine] Press Release
Matthew Ellis Receives Stand Up to Cancer’s Laura Ziskin Prize for Breast Cancer Research
Dr. Matthew Ellis, director of the Lester and Sue Smith Breast Center at Baylor College of Medicine, has received the Stand Up To Cancer 2015 Laura Ziskin Prize to advance studies of the defective DNA repair mechanisms in breast cancer. [Baylor College of Medicine] Press Release
Cancer Research UK Invests £15 Million in New Major Centers
Cancer Research UK launches major centers in Oxford, Manchester and Cambridge, with each receiving £5 million to boost their work in personalized cancer medicine and early detection research. [Cancer Research UK] Press Release
OHSU Sets Fundraising Record by Meeting $1 Billion Challenge from Nike Co-Founder and Wife
Oregon Health & Science University (OHSU) announced it met Nike co-founder Phil Knight and his wife Penny’s $1 billion challenge by raising $500 million in less than two years to earn the Knights’ matching gift and set a fundraising record. [Oregon Health & Science University] Press Release
From our sponsor: Learn about air-liquid interface culture for respiratory research.
Watch the video.